Heron Therapeutics
在场
高管
查看带有其 16 名主要高管的组织结构图
Heron Therapeutics 搜索最多的简介
高管在Heron Therapeutics变化
- Michael Kaseta已作为Director加入公司 (新闻发布的2024十一月5号).
- Brett Fleshman已作为Chief Business Officer加入公司 (新闻发布的2024九月3号).
创建提醒
跟踪 Heron Therapeutics 的高管变动
生物技术
Heron Therapeutics 拥有 2,337 家竞争者，其中包括 Eurofins (卢森堡)、Lonza (瑞士) 和 Biogen (美国(美洲))。
Popular M&A news in 生物技术
- Aadi Bioscience 刚刚宣布为 100 筹款数百万美元。 (公布2024十二月20号).
- OraSure Technologies has announced the acquisition of Sherlock Biosciences (公布2024十二月20号).
- SiteOne Therapeutics 刚刚宣布为 100 筹款数百万美元。 (公布2024十二月20号).
生物技术 行业的其他推荐联系人
消息
Heron Therapeutics 的最新新闻稿
- Heron Therapeutics to Report Second Quarter 2022 Financial Results on Tuesday, August 9, 2022 - Heron Therapeutics
- Heron Therapeutics Announces Restructuring and Cost Reduction Plan to Address Market Dynamics and Prepare for Long-Term Sustainability - Heron Therapeutics
- News Releases - Heron Therapeutics
- News Releases - Heron Therapeutics
- Heron Therapeutics Announces Publication Showing ZYNRELEF® as the Foundation of a Perioperative Non-Opioid Multimodal Analgesic Regimen Reduced Severe Pain and Opioid Use in Patients Undergoing Total Knee Arthroplasty - Heron Therapeutics
- Heron Therapeutics to Present at the 2022 Jefferies Global Healthcare Conference - Heron Therapeutics
- Heron Therapeutics Presents ZYNRELEF® Data at the Society for Obstetric Anesthesia and Perinatology 54th Annual Meeting - Heron Therapeutics
- Heron Therapeutics Announces Financial Results for the Three Months Ended March 31, 2022 and Highlights Recent Corporate Updates - Heron Therapeutics
- Heron Therapeutics to Report First Quarter 2022 Financial Results on Monday, May 9, 2022 - Heron Therapeutics
- Heron Therapeutics Receives European Commission Authorization for ZYNRELEF™ (HTX-011) for the Treatment of Postoperative Pain | Heron Therapeutics
- View more press releases Close
通过电子邮件
